In April 2018 Boston Scientific announced the triple closure of its acquisitions of women's health company, nVision Medical Corporation, NxThera and Securus Medical Group, Inc. for up to $50 million. In July, Boston announced it would acquire Cryterion Medical, Inc, Veniti, Inc., in August Augmenix, Inc. and Claret Medical, Inc. and in October In late November Boston announce they would acquire UK medical device maker, BTG plc, for $4.2 billion. In late December, the company announced it would acquire Millipede, Inc for $325 million - after previously investing $90 million in the company.